Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
Delilah Hendriks, Jos F. Brouwers, Karien M. Hamer, Maarten H. Geurts, Léa Luciana, Simone Massalini, Carmen López‐Iglesias, Peter J. Peters, Maria J. Rodríguez Colman, Susana M. Chuva de Sousa Lopes, Benedetta Artegiani, Hans Clevers (2023). Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. , 41(11), DOI: https://doi.org/10.1038/s41587-023-01680-4.
